ArticleIndian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine2026
Assessing Quality of life of Patients with Cataract and Glaucoma using Generic and Vision-Specific Instruments in India.
Article in Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The study assesses the 'health-related quality of life' (HRQoL) in patients with cataract and glaucoma, examines its determinants through both generic and vision-specific instruments, and evaluates the degree of agreement between the two HRQoL assessment tools. Methods: A facility-based survey was carried out among 541 participants (297 glaucoma patients and 244 cataract patients) in outpatient settings of tertiary facility from January to June 2024. After obtaining informed consent, the participants were interviewed about their sociodemographic characteristics, medical history, and HRQoL. The mean utility value for the 'EuroQol five dimensions five levels' ('EQ-5D-5L') and the composite score for the 'National Eye Institute Visual Function Questionnaire-25' ('NEI-VFQ-25') were calculated. Factors influencing HRQoL were analyzed through a generalized linear regression model. Additionally, Pearson's correlation coefficient was determined to evaluate the correlation between the HRQoL derived through vision-specific and generic measures. Results: The 'EQ-5D-5L' utility values were 0.74 (0.71-0.77) and 0.87 (0.85-0.89) in glaucoma and cataracts, respectively. The 'NEI-VFQ-25' composite score was 74.8 (72.2-77.2) in glaucoma and 79.3 (77.3-81.2) in cataract. Visual acuity was significantly associated with HRQoL in both disorders. 'NEI-VFQ-25' score had a strong and moderate correlation with EQ-5D-5L value in glaucoma and cataract, respectively. Conclusion: The decrement in HRQoL in patients with glaucoma and cataract underscores the need to prioritize policies for improving awareness, early detection, and management of these diseases. While the 'EQ-5D-5L' adequately captures HRQoL in glaucoma, the incorporation of vision-specific bolt-on dimension to the generic instrument in cataract should be explored.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.